The systemic impact of EEC-secreted GLP1 on food intake, appetite, and glucose homeostasis and its role in the pathogenesis and treatment of metabolic disorders, including obesity, have been the subject of extensive investigation. The gene discussed is GCG; the disease is obesity disorder.